Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical setting. [electronic resource]
Producer: 20091028Description: 1252-7 p. digitalISSN:- 1440-1746
- Adalimumab
- Adolescent
- Adult
- Anti-Inflammatory Agents -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Australia
- Child
- Colitis, Ulcerative -- diagnosis
- Crohn Disease -- diagnosis
- Drug Administration Schedule
- Female
- Gastrointestinal Agents -- administration & dosage
- Humans
- Infliximab
- Male
- Middle Aged
- Prospective Studies
- Remission Induction
- Severity of Illness Index
- Time Factors
- Treatment Failure
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.